Tag: Global Health Aid

 

Publications

Millions Saved (2016) is a new edition of detailed case studies on the attributable impact of global health programs at scale. As an input to the book, this paper provides an independent assessment of the cost-effectiveness of a selection of the cases using ex post information from impact evaluations, with the objective of illustrating how economic evaluation can be used in decision making and to provide further evidence on the extent of health gains produced for the funding provided.

Publications

Donors play a significant role in funding medicines and other commodities in global health. Of the approximately US $28.2 billion spent by donors in 2010, approximately 40% went towards medicines, vaccines and other health commodities, mainly in sub-Saharan Africa. The efficiency of this spend is therefore of great concern, given the large variability in supply chain costs.

Spatial Relationships: Does Global Health Aid Go Where It’s Needed?

Blog Post

This is a joint post with Yuna Sakuma

Funding for health in any country doesn’t always go where it’s needed most.  But this is particularly true where donors and national governments have to decide how to distribute scarce resources within a country and coordinate their efforts.  Often, governments don’t know where donors are spending their health funds, and vice versa, which can result in a misalignment between funding and need.  

Addressing Entitlements: How the US Can Better Support Lifelong Global AIDS Treatment

Blog Post

Many currently believe that US domestic entitlements are too large, but disregard the fact that the PEPFAR program has created a new class of moral entitlements overseas – in the form of 4 million and counting people receiving US-supported life-sustaining AIDS treatment in low and middle income countries around the world.  Of course, the approximately $2.7 billion that the US spent in 2011 (53% of the $5.3B 2011 budget) on supporting the treatment of these people is only about two-tenths of a per cent of the US’s annual expenditure on Socia

Ethiopia’s AIDS Spending Cliff

Blog Post

There’s an AIDS spending cliff in Ethiopia and the government is already in free fall. Next year, Ethiopia will experience a 79% reduction in US HIV financing from PEPFAR. The announcement of these cuts came with an explanation that PEPFAR was “free(ing) up resources by reducing programs in lower HIV prevalence countries” (see blog). Further, Global Fund monies have gone almost completely undisbursed in 2012. These cuts in spending might be warranted due to epidemiological trends and improved efficiency, or might cripple progress as health programs dependent on external donors are cut back. The truth is, with the current poor status of basic information on beneficiaries and costs, it’s difficult to judge whether these cuts are good or bad.

AIDS Spending a Good Investment? Maybe Not

Blog Post

Video of the debate may be viewed here.

Yesterday was an exciting day for me. In a debate at the World Bank timed to coincide with the International AIDS Conference a colleague and I took an unpopular position against two development celebrities in front of a potentially hostile audience and changed some minds. The proposition was:

“Continued AIDS investment by donors and governments is a sound investment, even in a resource constrained environment”

Will the Agenda for Child Survival Survive?

Blog Post

Saving kids: Who doesn’t want to do that? Though relatively uncontroversial (say, compared to saving drug addicts and sex workers), the agenda for child survival is not new. In fact, it’s a (relatively) old agenda in global health, arguably dating back to the time of UNICEF's third Executive Director James Grant (1980-1995) who pushed to recognize the “global silent emergency” and to reduce preventable child deaths.

What Indicators Reveal about Interest in Global Health: The World Health Statistics Report

Blog Post

A few days ago the World Health Statistics 2012 Report released its annual compendium of statistics. No doubt, it was a lot of work to compile—to verify every number in every cell, for each country and indicator. The WHO should be commended for providing this invaluable global public good. A sincere request: the Report would be more user-friendly and useful if the Report came with spreadsheets in downloadable tables (much like the World Malaria Report), and if the Report’s tables were consistent with their main database, the Global Health Observatory (GHO). For example, the coverage measures of oral rehydration therapy (ORT) which were included in the Report are absent from the GHO, as far as we can tell. (On an unrelated note, we did notice that the GHO recently added hand-washing as an indicator, perhaps in response to a recent blog—kudos to WHO!)

Pages